- Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group. Hesketh, P., Navari, R., Grote, T., Gralla, R., Hainsworth, J., Kris, M., Anthony, L., Khojasteh, A., Tapazoglou, E., Benedict, C., Hahne, W. J. Clin. Oncol. (1996)